From owner-doc-jp@jp.FreeBSD.org Fri Sep 12 06:40:31 2014
Received: (from daemon@localhost)
	by castle.jp.freebsd.org (8.11.6p2+3.4W/8.11.3) id s8BLeVe12596;
	Fri, 12 Sep 2014 06:40:31 +0900 (JST)
	(envelope-from owner-doc-jp@jp.FreeBSD.org)
Received: from dsl-emcali-186.27.166.186.emcali.net.co (dsl-emcali-186.27.166.186.emcali.net.co [186.27.166.186])
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) with ESMTP/inet id s8BLeJT12579;
	Fri, 12 Sep 2014 06:40:19 +0900 (JST)
	(envelope-from furyg3090@rorywoolridge.com)
Message-ID: <000d01cfce08$ec1fa1f0$6400a8c0@furyg3090>
From: "Grady Helton" <furyg3090@rorywoolridge.com>
To: <doc-jp@jp.FreeBSD.org>
MIME-Version: 1.0
Content-Type: text/plain;
	format=flowed;
	charset="iso-8859-1";
	reply-type=original
Content-Transfer-Encoding: 7bit
X-Priority: 3
X-MSMail-Priority: Normal
X-Mailer: Microsoft Outlook Express 6.00.2900.2180
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.2180
X-Spam: Not detected
Reply-To: doc-jp@jp.FreeBSD.org
Precedence: list
Date: Thu, 11 Sep 2014 16:39:53 -0500
X-Sequence: doc-jp 127445
Subject: [doc-jp 127445] Very simple
Sender: owner-doc-jp@jp.FreeBSD.org
X-Originator: furyg3090@rorywoolridge.com
X-Distribute: distribute version 2.1 (Alpha) patchlevel 24e+060209

Very simple, you can take two capsules daily with food and water, one before breakfast andone before lunch, thats it - 

www.mecadestop.com

------













Study authors focused on records from one Canadian hospital. In the six months prior to Angelina's revelation that she carried the BRCA1 mutation (which leads to a higher risk of breast and ovarian cancer), 487 women were referred for genetic testing. In the six months after her announcement, 916 women were referred.

It may be that both women and doctors who heard Jolies story contributed to this 90 percent increase, note the researchers. According to this study, the number of women who qualified for genetic testing doubled, as did the number of women found to be BRCA1 mutation carriers, plus those who had another breast- and ovarian-cancer linked gene, BRCA2.

"While this is a small study, it shows the profound impact that prominent figures like Jolie can have on public awareness of health issues," said lead study author Jacques Raphael, M.D., clinical fellow at Sunnybrook Odette Cancer Centre in Toronto, Canada, in a statement.




Now, over a year later, researchers are revealing just how her public announcement has changed the way women take charge of their health. In fact, researchers attribute a surge in the number of women being referred for genetic testing to this "Angelina Effect," according to a yet-to-be-published study presented at the 2014 American Society of Clinical Oncology Breast Cancer Symposium.






